Dare Bioscience Inc (DARE)
0.4133
-0.02
(-4.02%)
USD |
NASDAQ |
May 31, 16:00
0.41
0.00 (0.00%)
After-Hours: 20:00
Dare Bioscience Stock Buybacks (Quarterly): -0.2151M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.2151M |
December 31, 2023 | -0.7858M |
September 30, 2023 | -8.109M |
June 30, 2023 | -0.4522M |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | -1.219M |
March 31, 2022 | |
December 31, 2021 | -15.73M |
September 30, 2021 | -35.01M |
June 30, 2021 | -13.25M |
March 31, 2021 | -11.32M |
December 31, 2020 | -8.455M |
September 30, 2020 | -5.278M |
June 30, 2020 | -4.022M |
March 31, 2020 | -5.223M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | -5.152M |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.0025M |
September 30, 2018 | 0.0812M |
Date | Value |
---|---|
June 30, 2018 | 0.0022M |
March 31, 2018 | -10.20M |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | |
September 30, 2016 | 0.041M |
June 30, 2016 | 0.00 |
March 31, 2016 | -0.041M |
December 31, 2015 | 0.00 |
September 30, 2015 | -0.156M |
June 30, 2015 | -37.25M |
March 31, 2015 | -2.411M |
December 31, 2014 | -0.001M |
September 30, 2014 | -0.006M |
June 30, 2014 | -59.97M |
March 31, 2014 | -0.027M |
December 31, 2013 | -0.019M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | -0.016M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-35.01M
Minimum
Sep 2021
--
Maximum
Sep 2019
-6.012M
Average
-4.022M
Median
Jun 2020
Stock Buybacks (Quarterly) Benchmarks
Altimmune Inc | -0.169M |
Verastem Inc | -- |
Oragenics Inc | -1.839M |
Actinium Pharmaceuticals Inc | -14.70M |
Orgenesis Inc | -2.36M |